Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	ArfGap	ARAP3 AGAP9 AGAP7P AGAP4 AGAP6	3.07e-06	29	149	5	SM00105
Domain	ARFGAP	ARAP3 AGAP9 AGAP7P AGAP4 AGAP6	3.07e-06	29	149	5	PS50115
Domain	ArfGap	ARAP3 AGAP9 AGAP7P AGAP4 AGAP6	3.07e-06	29	149	5	PF01412
Domain	ArfGAP	ARAP3 AGAP9 AGAP7P AGAP4 AGAP6	3.07e-06	29	149	5	IPR001164
Domain	A1A_glycop	ORM1 ORM2	6.32e-05	2	149	2	IPR001500
Domain	MINDY_domain	MINDY2 MINDY1	6.32e-05	2	149	2	IPR033979
Domain	DUF544	MINDY2 MINDY1	6.32e-05	2	149	2	PF04424
Domain	MINDY	MINDY2 MINDY1	6.32e-05	2	149	2	IPR007518
Domain	Keratin_matx	KRTAP3-3 KRTAP3-2	1.89e-04	3	149	2	PF04579
Domain	Keratin_matx	KRTAP3-3 KRTAP3-2	3.75e-04	4	149	2	PD010562
Domain	TF_AP2	TFAP2E TFAP2C	6.22e-04	5	149	2	IPR004979
Domain	TF_AP2_C	TFAP2E TFAP2C	6.22e-04	5	149	2	IPR013854
Domain	Keratin_matx	KRTAP3-3 KRTAP3-2	6.22e-04	5	149	2	IPR007659
Domain	TF_AP-2	TFAP2E TFAP2C	6.22e-04	5	149	2	PF03299
Domain	EGF_CA	FBLN5 MATN1 EGFL6 HMCN1 NOTCH3	6.26e-04	86	149	5	PF07645
Domain	PH_dom-like	NUMBL EPB41L5 TNS2 PLEKHN1 ARHGEF17 CDC42BPB ARAP3 AGAP9 AGAP7P AGAP4 AGAP6	6.30e-04	426	149	11	IPR011993
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PLXNA3 DPH2 ABCA2 HIVEP2 TMEM94 TMCO6 REV3L EDC4 WNK1 FAAP100 CDC42BPB CCDC142 MST1R NHSL1 ARAP3 RPAP1 SCN5A MLLT6 PLEC PRRT4 ELL HR	3.23e-09	1105	152	22	35748872
Pubmed	GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins.	AGAP9 AGAP7P AGAP4 AGAP6	4.34e-08	9	152	4	12640130
Pubmed	AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release.	AGAP9 AGAP7P AGAP4 AGAP6	7.22e-08	10	152	4	20664521
Pubmed	AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase.	AGAP9 AGAP7P AGAP4 AGAP6	1.13e-07	11	152	4	15381706
Pubmed	The Endosome Localized Arf-GAP AGAP1 Modulates Dendritic Spine Morphology Downstream of the Neurodevelopmental Disorder Factor Dysbindin.	AGAP9 AGAP7P AGAP4 AGAP6	2.43e-07	13	152	4	27713690
Pubmed	GTP-binding protein-like domain of AGAP1 is protein binding site that allosterically regulates ArfGAP protein catalytic activity.	AGAP9 AGAP7P AGAP4 AGAP6	3.39e-07	14	152	4	22453919
Pubmed	The ATG5 interactome links clathrin-mediated vesicular trafficking with the autophagosome assembly machinery.	MYADM TTC28 WDR7 EDC4 WNK1 CDC42BPB HEATR6 SDC1 RAVER1	8.55e-07	230	152	9	35449600
Pubmed	Identification of new ciliary signaling pathways in the brain and insights into neurological disorders.	LRRC57 ABL2 TMEM94 GRM5 KIRREL3 DENND4B C1QB AGAP9 AGAP7P AGAP4 AGAP6	1.86e-06	405	152	11	38187761
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	ABCA2 TTC28 EPB41L5 NLRP1 MINDY2 PALB2 EIF2S3 PRPF19 AGAP7P AGAP4 RABGGTA	1.73e-05	513	152	11	25798074
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	LRRC57 ABL2 WDR7 TMEM94 EPB41L5 PNO1 DAPK1 NCBP1 TTPAL PLEKHN1 CDC42BPB PRIM2 NBR1	1.79e-05	719	152	13	35337019
Pubmed	Distal promoter regions are responsible for differential regulation of human orosomucoid-1 and -2 gene expression and acute phase responses.	ORM1 ORM2	1.90e-05	2	152	2	24389491
Pubmed	A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation.	ORM1 ORM2	1.90e-05	2	152	2	15253437
Pubmed	Selective binding of coumarin enantiomers to human alpha1-acid glycoprotein genetic variants.	ORM1 ORM2	1.90e-05	2	152	2	16290938
Pubmed	Retinoids increase alpha-1 acid glycoprotein expression at the transcriptional level through two distinct DR1 retinoic acid responsive elements.	ORM1 ORM2	1.90e-05	2	152	2	15157739
Pubmed	Orosomucoid-1 Arises as a Shared Altered Protein in Two Models of Multiple Sclerosis.	ORM1 ORM2	1.90e-05	2	152	2	37949310
Pubmed	Comparison of alpha-1-acid glycoprotein isoforms from healthy and cancer patients by capillary IEF.	ORM1 ORM2	1.90e-05	2	152	2	17987628
Pubmed	α1-Acid Glycoprotein Enhances the Immunosuppressive and Protumor Functions of Tumor-Associated Macrophages.	ORM1 ORM2	1.90e-05	2	152	2	34210751
Pubmed	Orosomucoid 1 promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing macrophage M2 polarization.	ORM1 ORM2	1.90e-05	2	152	2	37640741
Pubmed	An acute phase protein α1-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action.	ORM1 ORM2	1.90e-05	2	152	2	33846468
Pubmed	Transcriptome Analysis Uncovers a Growth-Promoting Activity of Orosomucoid-1 on Hepatocytes.	ORM1 ORM2	1.90e-05	2	152	2	28927749
Pubmed	α1-Acid glycoprotein decreases neutrophil migration and increases susceptibility to sepsis in diabetic mice.	ORM1 ORM2	1.90e-05	2	152	2	22415874
Pubmed	Structure of 1 -acid glycoprotein. The complete amino acid sequence, multiple amino acid substitutions, and homology with the immunoglobulins.	ORM1 ORM2	1.90e-05	2	152	2	4711474
Pubmed	CNOT6/6L-mediated mRNA degradation in ovarian granulosa cells is a key mechanism of gonadotropin-triggered follicle development.	CNOT6 CNOT6L	1.90e-05	2	152	2	34788619
Pubmed	Notch3 signaling is associated with MUC5AC expression and favorable prognosis in patients with small intestinal adenocarcinomas.	MUC5AC NOTCH3	1.90e-05	2	152	2	24810798
Pubmed	Structure and expression of the genes coding for human alpha 1-acid glycoprotein.	ORM1 ORM2	1.90e-05	2	152	2	2822385
Pubmed	Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation.	ORM1 ORM2	1.90e-05	2	152	2	20442402
Pubmed	Orosomucoid1: Involved in vascular endothelial growth factor-induced blood-brain barrier leakage after ischemic stroke in mouse.	ORM1 ORM2	1.90e-05	2	152	2	25264156
Pubmed	Molecular characterization and acute phase expression of the multiple Mus caroli alpha 1-acid glycoprotein (AGP) genes. Differences in glucocorticoid stimulation and regulatory elements between the rat and mouse AGP genes.	ORM1 ORM2	1.90e-05	2	152	2	2354997
Pubmed	Structural heterogeneity of glycoform of alpha-1 Acid glycoprotein in alcoholic cirrhosis patients.	ORM1 ORM2	1.90e-05	2	152	2	25408356
Pubmed	Nucleotide sequence of the mouse alpha 1-acid glycoprotein gene 1.	ORM1 ORM2	1.90e-05	2	152	2	3676251
Pubmed	Structure and characterisation of a duplicated human alpha 1 acid glycoprotein gene.	ORM1 ORM2	1.90e-05	2	152	2	2970990
Pubmed	The disulfide bonds of alpha1-acid glycoprotein.	ORM1 ORM2	1.90e-05	2	152	2	4603214
Pubmed	Orm2 Deficiency Aggravates High-Fat Diet-Induced Obesity through Gut Microbial Dysbiosis and Intestinal Inflammation.	ORM1 ORM2	1.90e-05	2	152	2	37853937
Pubmed	Blocking Notch3 Signaling Abolishes MUC5AC Production in Airway Epithelial Cells from Individuals with Asthma.	MUC5AC NOTCH3	1.90e-05	2	152	2	31922915
Pubmed	No association of DAPK1 and ABCA2 SNPs on chromosome 9 with Alzheimer's disease.	ABCA2 DAPK1	1.90e-05	2	152	2	18336955
Pubmed	Molecular cloning of syndecan, an integral membrane proteoglycan.	MITF SDC1	1.90e-05	2	152	2	2494194
Pubmed	A mouse gene family associated with a major submaxillary-gland glycoprotein.	ORM1 ORM2	1.90e-05	2	152	2	3977853
Pubmed	Structure and expression of mouse alpha 1-acid glycoprotein gene-3 (AGP-3).	ORM1 ORM2	1.90e-05	2	152	2	1605854
Pubmed	The Protexin complex counters resection on stalled forks to promote homologous recombination and crosslink repair.	REV3L SCAI	1.90e-05	2	152	2	34597596
Pubmed	Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein.	ORM1 ORM2	1.90e-05	2	152	2	1567356
Pubmed	Plasma alpha-1-acid glycoprotein as a potential predictive biomarker for non-haematological adverse events of docetaxel in breast cancer patients.	ORM1 ORM2	1.90e-05	2	152	2	28554261
Pubmed	Evidence for the existence of multiple alpha 1-acid glycoprotein genes in the mouse.	ORM1 ORM2	1.90e-05	2	152	2	3003086
Pubmed	Interaction of acute-phase-inducible and liver-enriched nuclear factors with the promoter region of the mouse alpha 1-acid glycoprotein gene-1.	ORM1 ORM2	1.90e-05	2	152	2	1371400
Pubmed	Structure of human alpha1-acid glycoprotein and its high-affinity binding site.	ORM1 ORM2	1.90e-05	2	152	2	12480518
Pubmed	Orosomucoid in liver diseases.	ORM1 ORM2	1.90e-05	2	152	2	34963738
Pubmed	Genetic variations of orosomucoid genes associated with serum alpha-1-acid glycoprotein level and the pharmacokinetics of paclitaxel in Japanese cancer patients.	ORM1 ORM2	1.90e-05	2	152	2	21638284
Pubmed	The bile acid induced hepatokine orosomucoid suppresses adipocyte differentiation.	ORM1 ORM2	1.90e-05	2	152	2	33168190
Pubmed	Mitigation of non-alcoholic steatohepatitis via recombinant Orosomucoid 2, an acute phase protein modulating the Erk1/2-PPARγ-Cd36 pathway.	ORM1 ORM2	1.90e-05	2	152	2	37355990
Pubmed	Molecular cloning of cDNAs corresponding to two genes of alpha 1-acid glycoprotein and characterization of two alleles of AGP-1 in the mouse.	ORM1 ORM2	1.90e-05	2	152	2	2475311
Pubmed	The Ccr4a (CNOT6) and Ccr4b (CNOT6L) deadenylase subunits of the human Ccr4-Not complex contribute to the prevention of cell death and senescence.	CNOT6 CNOT6L	1.90e-05	2	152	2	21233283
Pubmed	A synthetic retinoic acid receptor agonist Am80 ameliorates renal fibrosis via inducing the production of alpha-1-acid glycoprotein.	ORM1 ORM2	1.90e-05	2	152	2	32651445
Pubmed	Isoform differentiation of intact AGP from human serum by capillary electrophoresis-mass spectrometry.	ORM1 ORM2	1.90e-05	2	152	2	20617306
Pubmed	alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans.	ORM1 ORM2	1.90e-05	2	152	2	7795416
Pubmed	Investigation of genetic variants of alpha-1 acid glycoprotein by ultra-performance liquid chromatography-mass spectrometry.	ORM1 ORM2	1.90e-05	2	152	2	19018521
Pubmed	Sexually dimorphic expression of the X-linked gene Eif2s3x mRNA but not protein in mouse brain.	EIF2S3B EIF2S3	1.90e-05	2	152	2	16325480
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ABCA2 FEM1C CNOT6 PASK AP5Z1 AGAP9 AGAP7P AGAP4 AGAP6 NBR1 MINDY1	2.29e-05	529	152	11	14621295
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	ABL2 NUMBL WDR7 GRM5 AGAP9 AGAP7P AGAP4 AGAP6	3.53e-05	281	152	8	28706196
Pubmed	Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice.	WDR7 ASH1L GEN1	4.40e-05	16	152	3	16096065
Pubmed	Dynamic expression of Syndecan-1 during hair follicle morphogenesis.	EDAR SDC1	5.68e-05	3	152	2	19427408
Pubmed	Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes.	ORM1 ORM2	5.68e-05	3	152	2	9455924
Pubmed	Hepatic posttranscriptional network comprised of CCR4-NOT deadenylase and FGF21 maintains systemic metabolic homeostasis.	CNOT6 CNOT6L	5.68e-05	3	152	2	30926667
Pubmed	Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo.	HLA-DQA1 ITGAX	5.68e-05	3	152	2	9053454
Pubmed	CNOT6L couples the selective degradation of maternal transcripts to meiotic cell cycle progression in mouse oocyte.	CNOT6 CNOT6L	5.68e-05	3	152	2	30478191
Pubmed	Chemical-induced chromatin remodeling reprograms mouse ESCs to totipotent-like stem cells.	TFAP2C SLC16A3	5.68e-05	3	152	2	35143761
Pubmed	Circulating, soluble forms of major histocompatibility complex antigens are not exosome-associated.	HLA-DQA1 CIITA	5.68e-05	3	152	2	17072917
Pubmed	Mapping of a putative genetic locus determining ethanol intake in the mouse.	ORM1 ORM2	5.68e-05	3	152	2	3676756
Pubmed	Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells.	ORM1 ORM2	5.68e-05	3	152	2	8774350
Pubmed	Mouse alpha-1-microglobulin/bikunin precursor: cDNA analysis, gene evolution and physical assignment of the gene next to the orosomucoid locus.	ORM1 ORM2	5.68e-05	3	152	2	7689339
Pubmed	Differential interactions and structural stability of chitosan oligomers with human serum albumin and α-1-glycoprotein.	ORM1 ORM2	5.68e-05	3	152	2	24359035
Pubmed	Revisiting the specificity of the MHC class II transactivator CIITA in vivo.	HLA-DQA1 CIITA	5.68e-05	3	152	2	16703565
Pubmed	MINDY-1 Is a Member of an Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes.	MINDY2 MINDY1	5.68e-05	3	152	2	27292798
Pubmed	Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality.	ORM1 ORM2	5.68e-05	3	152	2	7931089
Pubmed	Mechanism of activation and regulation of deubiquitinase activity in MINDY1 and MINDY2.	MINDY2 MINDY1	5.68e-05	3	152	2	34529927
Pubmed	Dexamethasone regulation of alpha 1-acid glycoprotein and other acute phase reactants in rat liver and hepatoma cells.	ORM1 ORM2	5.68e-05	3	152	2	6184374
Pubmed	Human alpha1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages.	ORM1 ORM2	5.68e-05	3	152	2	11336643
Pubmed	Fatigue-induced Orosomucoid 1 Acts on C-C Chemokine Receptor Type 5 to Enhance Muscle Endurance.	ORM1 ORM2	5.68e-05	3	152	2	26740279
Pubmed	Identification of a new acute phase protein.	ORM1 ORM2	5.68e-05	3	152	2	7545679
Pubmed	The genetic control of sialadenitis versus arthritis in a NOD.QxB10.Q F2 cross.	ORM1 ORM2	5.68e-05	3	152	2	11782015
Pubmed	The hepatic orosomucoid/α1-acid glycoprotein gene cluster is regulated by the nuclear bile acid receptor FXR.	ORM1 ORM2	5.68e-05	3	152	2	23861371
Pubmed	Differential expression of the mouse alpha 1-acid glycoprotein genes (AGP-1 and AGP-2) during inflammation and aging.	ORM1 ORM2	5.68e-05	3	152	2	2054382
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	ASH1L NHSL1 RPAP1 N4BP2 USP35 MINDY1	6.00e-05	153	152	6	10718198
Pubmed	RNF219 attenuates global mRNA decay through inhibition of CCR4-NOT complex-mediated deadenylation.	CNOT6 CNOT6L RAVER1	8.83e-05	20	152	3	34887419
Pubmed	Autoantigen-specific interactions with CD4+ thymocytes control mature medullary thymic epithelial cell cellularity.	HLA-DQA1 CIITA	1.13e-04	4	152	2	18799151
Pubmed	Transcriptional induction of the alpha-1 acid glycoprotein (AGP) gene by synergistic interaction of two alternative activator forms of AGP/enhancer-binding protein (C/EBP beta) and NF-kappaB or Nopp140.	ORM1 ORM2	1.13e-04	4	152	2	8754826
Pubmed	MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity.	HLA-DQA1 CIITA	1.13e-04	4	152	2	20696698
Pubmed	Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression.	MUC5AC NOTCH3	1.13e-04	4	152	2	22691042
Pubmed	Suppression of MEHMO Syndrome Mutation in eIF2 by Small Molecule ISRIB.	EIF2S3B EIF2S3	1.13e-04	4	152	2	31836389
Pubmed	MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency.	HLA-DQA1 CIITA	1.13e-04	4	152	2	16849401
Pubmed	Deadenylase-dependent mRNA decay of GDF15 and FGF21 orchestrates food intake and energy expenditure.	CNOT6 CNOT6L	1.13e-04	4	152	2	35385705
Pubmed	α(1)-Acid glycoprotein up-regulates CD163 via TLR4/CD14 protein pathway: possible protection against hemolysis-induced oxidative stress.	ORM1 ORM2	1.13e-04	4	152	2	22807450
Pubmed	The Acute-Phase Protein Orosomucoid Regulates Food Intake and Energy Homeostasis via Leptin Receptor Signaling Pathway.	ORM1 ORM2	1.13e-04	4	152	2	27207522
Pubmed	The fifth adaptor protein complex.	AP5Z1 AP5M1	1.13e-04	4	152	2	22022230
Pubmed	DENN domain proteins: regulators of Rab GTPases.	DENND4B DENND2C	1.13e-04	4	152	2	21330364
Pubmed	A proteomic analysis of human bile.	ORM1 ORM2 HPX	1.19e-04	22	152	3	15084671
Pubmed	Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complex.	CNOT6 CNOT6L RAVER1	1.19e-04	22	152	3	18377426
Pubmed	Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice.	HLA-DQA1 CIITA	1.88e-04	5	152	2	9491996
Pubmed	Analysis of transcription factor AP-2 expression and function during mouse preimplantation development.	TFAP2E TFAP2C	1.88e-04	5	152	2	16672719
Pubmed	Analysis of coding-polymorphisms in NOTCH-related genes reveals NUMBL poly-glutamine repeat to be associated with schizophrenia in Brazilian and Danish subjects.	NUMBL NOTCH3	1.88e-04	5	152	2	16899352
Pubmed	Lymph node stromal cells acquire peptide-MHCII complexes from dendritic cells and induce antigen-specific CD4⁺ T cell tolerance.	HLA-DQA1 CIITA	1.88e-04	5	152	2	24842370
Pubmed	[Application of reverse transcription-multiplex nested PCR to detect MLL rearrangement in AML-M4/M5].	MLLT6 ELL	1.88e-04	5	152	2	16086288
Cytoband	3p21.31	TOPAZ1 DALRD3 USP19 ATRIP PRSS50	2.18e-05	100	152	5	3p21.31
Cytoband	19q13.2	CYP2F1 CD177 DMAC2 SYCN DMRTC2	2.27e-04	164	152	5	19q13.2
Cytoband	Ensembl 112 genes in cytogenetic band chr3p21	TOPAZ1 DALRD3 USP19 MST1R ATRIP PRSS50	6.78e-04	316	152	6	chr3p21
GeneFamily	ArfGAPs	ARAP3 AGAP9 AGAP7P AGAP4 AGAP6	7.61e-07	33	95	5	395
GeneFamily	Ankyrin repeat domain containing	DAPK1 ANKMY1 FEM1C ARAP3 AGAP9 AGAP7P AGAP4 AGAP6 NOTCH3	5.13e-06	242	95	9	403
GeneFamily	X-linked mental retardation\|Rho GTPase activating proteins\|BAR-PH domain containing	AGAP9 AGAP4 AGAP6	9.06e-05	17	95	3	1291
GeneFamily	Fibulins	FBLN5 HMCN1	7.49e-04	8	95	2	556
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHN1 ARAP3 AGAP9 AGAP7P AGAP4 AGAP6	7.62e-04	206	95	6	682
GeneFamily	CCR4-NOT transcription complex	CNOT6 CNOT6L	1.46e-03	11	95	2	1023
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	TFPI AGAP9 AGAP7P AGAP4 AGAP6	5.38e-06	44	151	5	MM485
Coexpression	GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP	ABCA2 GPAT3 TNS2 HEXD ITGAX TFPI TRPM5 MITF	2.18e-05	200	151	8	M3529
Coexpression	GSE27786_BCELL_VS_CD4_TCELL_UP	MYADM LRRC57 HMGXB4 DMAC2 MINDY2 DALRD3 USF3 SCAI	2.18e-05	200	151	8	M4799
ToppCell	facs-Lung-ENDOMUCIN-18m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PNO1 NLRP1 HEXD ITGAX MST1R CIITA USP35	1.49e-06	164	151	7	54f8f11d2fa899005530c08e7a1ee728c7b0799c
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DONSON GPAT3 PALB2 NHSL1 PASK DENND2C AP5M1	2.39e-06	176	151	7	3766e0533b103ec92ac75eba3df02e287efc53fa
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DONSON GPAT3 PALB2 NHSL1 PASK DENND2C AP5M1	2.39e-06	176	151	7	aa1bada2175d8370fc71939a607407155259d195
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_A2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	HMGXB4 CENPO ARMH1 ADAM28 DIPK2B CCDC142 SCAI	2.98e-06	182	151	7	03992d0ae519795239e4f2cc8e63f33c4482de6a
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 GPAT3 ITGAX ADAM28 GPR146 CIITA SEMA4A	3.83e-06	189	151	7	c81b38cda4525254fe4fa137a4c9bc9abe0363bb
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ARHGEF17 EGFL6 TFPI S1PR5 NHSL1 HMCN1 NOTCH3	3.83e-06	189	151	7	9c2492c38f27e4c699b40680652e4c64911cce52
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DQA1 GPAT3 ITGAX ADAM28 GPR146 CIITA SEMA4A	3.83e-06	189	151	7	807922b5ea0faddd3abfa9ec1b53f3f2b00e61bf
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_5\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA C1QB SEMA4A	4.10e-06	191	151	7	92c5a26b90a55831039220341d863cf2940f3c9b
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_5\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA C1QB SEMA4A	4.24e-06	192	151	7	6184163dbfca882824cb266bb9030d9f79e3acb0
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CCL\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	HLA-DQA1 GPAT3 DAPK1 ADAM28 SLC16A3 C1QB SEMA4A	5.02e-06	197	151	7	61bda9b5102fdbce902bb976d1aa62f2c799d2fb
ToppCell	mild_COVID-19-cDC\|World / disease group, cell group and cell class (v2)	HLA-DQA1 GPAT3 ITGAX ADAM28 GPR146 CIITA SEMA4A	5.02e-06	197	151	7	63e7b040c64f1e28b8db79980c7b580caa7d1b95
ToppCell	PBMC-Severe-Myeloid-cDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA C1QB SEMA4A	5.02e-06	197	151	7	22e4ffb5de483eaf78f14badf3d08db898e3b3dd
ToppCell	PBMC-Severe-Myeloid-cDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA C1QB SEMA4A	5.02e-06	197	151	7	346974c6c5809a3fe88cbf067e2d64c340310a31
ToppCell	PBMC-Severe-Myeloid-cDC-cDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA C1QB SEMA4A	5.02e-06	197	151	7	1ae45c1ec3b3f88e0c1f99de58c58b1ec1b968ee
ToppCell	COVID-19_Severe-Myeloid-cDC\|COVID-19_Severe / Disease group, lineage and cell class	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA C1QB SEMA4A	5.02e-06	197	151	7	843b0f1cc26864ee635df7938c77552ee06fe00b
ToppCell	PBMC-Severe-Myeloid-cDC-cDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA C1QB SEMA4A	5.02e-06	197	151	7	f78f44dcd7855c96f148678c1f416075aef71b4e
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P5-P5_2\|Striatum / BrainAtlas - Mouse McCarroll V32	TFAP2E PALB2 PASK EDAR HSD17B1	1.11e-05	86	151	5	2df674969383d93509ea9e201452cfda702fae40
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4\|Striatum / BrainAtlas - Mouse McCarroll V32	TFAP2E PALB2 PASK EDAR HSD17B1	1.11e-05	86	151	5	8ead39a100fa5aedf93a2206edd9828538f990a5
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFAP47 ANKMY1 HEATR6 TRPM5 EDAR AP5M1	1.50e-05	155	151	6	441fcb6d05364fc6f4973f0b973f1a80b573ce1f
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA PRSS50	1.61e-05	157	151	6	e9d0300361b06aec3c216f8af15f09e14b12a4da
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA PRSS50	1.67e-05	158	151	6	e9657d8960d499832f9f9b45b5a6f4388551b7e1
ToppCell	droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DAPK1 ARHGEF17 EGFL6 SLC16A3 C1QB ARHGEF37	2.13e-05	165	151	6	94a5211072464fc24592bb107a853ce832e816fe
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-DQA1 ITGAX ORM1 ORM2 CIITA SEMA4A	2.69e-05	172	151	6	cf46810dd1072b6f2171e5d9530351ddc79a055b
ToppCell	COVID-19_Mild-PLT_2\|COVID-19_Mild / Disease Group and Platelet Clusters	ABL2 TOPAZ1 HLA-DQA1 DMAC2 ARMH1 USP35	2.78e-05	173	151	6	d11705e56b6b21eec963ea224717f27680c781ed
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC2\|lymph-node_spleen / Manually curated celltypes from each tissue	CFAP47 HLA-DQA1 GPAT3 ITGAX CIITA MUC5AC	3.06e-05	176	151	6	72a3bbab0540ae3e3c94b9573cdb9298a024dbc4
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-9\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NUMBL HLA-DQA1 ZNF318 CDC42BPB ADAM28 CIITA	3.16e-05	177	151	6	ae55773c531099a9e94f44f01ba48b5e71dddc53
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	DAPK1 ITGAX NHSL1 MITF C1QB NOTCH3	3.48e-05	180	151	6	7be7d7a6906fff6dbdecd9cb013d855aba4eda2a
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABL2 MATN1 ITGAX CIITA C1QB SEMA4A	3.48e-05	180	151	6	66c7b02d85e32ba3e7530d0c4aff17e7525ccdd8
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDC42BPB HEATR6 PRIM2 SCN5A USP35 NOTCH3	3.58e-05	181	151	6	3fe648db1cb8326066d8bde3ca1287c5c9af19bd
ToppCell	3'_v3-bone_marrow-Myeloid_Dendritic-DC2\|bone_marrow / Manually curated celltypes from each tissue	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	3.81e-05	183	151	6	f482e4fe011fa450a475034b1e25587233855bdb
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_4\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	CD177 EIF2S3B TRIM21 USF3 ADGRF3 NBR1	3.81e-05	183	151	6	3cbe0175d05fd39bc430de1ef471ff2c5b56460e
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Aldh1a1_(SNc/VTA)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CIITA UCN HSD17B1 RIPPLY1	3.91e-05	56	151	4	fedec1be5368a82a75f640e84809e4270dd57c85
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Aldh1a1_(SNc/VTA)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CIITA UCN HSD17B1 RIPPLY1	3.91e-05	56	151	4	1c101711d20817f65314fcf45a4f99d0934206a8
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CD177 ITGAX ORM1 ORM2 SLC16A3 HPX	3.93e-05	184	151	6	7ecdf2645e9378cf2f5ce4557f2cf100e6f184ba
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ABL2 TTC28 REV3L TMEM215 HMCN1 SOCS5	3.93e-05	184	151	6	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	facs-Spleen-nan-3m-Lymphocytic-CD79a_B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DQA1 TTPAL ZNF318 CIITA HPX C1QB	4.30e-05	187	151	6	b51af2824e65734f333b1325117f4a2e88b17c23
ToppCell	facs-Spleen-nan-3m-Lymphocytic-B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DQA1 TTPAL ZNF318 CIITA HPX C1QB	4.30e-05	187	151	6	3ca3954f45f167e98a230f2847f0582d74fcd32e
ToppCell	Fetal_29-31_weeks-Immune-monocyte-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HLA-DQA1 GPAT3 ITGAX ADAM28 SLC16A3 CIITA	4.70e-05	190	151	6	ad297172a74a80ed5c10f921e15efd1da0fd2d6b
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	4.84e-05	191	151	6	6cda82a994f4b205cf54590c979d7c9f3be2b4c8
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	4.84e-05	191	151	6	4257f02856f3510981e9f84d465d91448d6126e2
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_5\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	4.98e-05	192	151	6	dfb9101622f7d2f2c392e850cff07becfc8c655e
ToppCell	356C-Myeloid-Dendritic-cDC2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	HLA-DQA1 GPAT3 REV3L ADAM28 GPR146 CIITA	4.98e-05	192	151	6	a7ccbea7c90c070d279d7ad3f2b5b7c0e3efd890
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_5\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	4.98e-05	192	151	6	d39133cf1a20af6f2970188630fc3b27a4cfc9c5
ToppCell	Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	WIPI1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.27e-05	194	151	6	3043f6230fa723037c8cf7123f611ae847b39fd4
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.27e-05	194	151	6	b16ed97eb6b7b7a220e943474c0d85c141b6e3a5
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.27e-05	194	151	6	2210f0755882d8f04edb4c109fb17c3f9149f6f7
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.27e-05	194	151	6	6af2971d83f5ad6aed16d0ceb8bfc52f3947bc10
ToppCell	COPD-Myeloid-Macrophage\|World / Disease state, Lineage and Cell class	ABL2 HLA-DQA1 ITGAX NHSL1 CIITA C1QB	5.27e-05	194	151	6	7d682408e9a6239a4e47befc9376e760cc3d133a
ToppCell	wk_20-22-Hematologic-Myeloid-DC2\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.27e-05	194	151	6	6a9bb5ad04aba13a4886fa27a96e28e90b6586e3
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.27e-05	194	151	6	5c60670ec24470225fabaa6071fdb4ef6e579840
ToppCell	IIH-mono3-\|IIH / Condition, Cell_class and T cell subcluster	WIPI1 GPAT3 ITGAX ADAM28 SLC16A3 C1QB	5.43e-05	195	151	6	28a858b04a7b413916c07a8d880f5ea02e985461
ToppCell	(3)_DC_2\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	ABL2 HLA-DQA1 GPAT3 ADAM28 CIITA C1QB	5.43e-05	195	151	6	3d656e13f1440a3624fe890f59343f7313b51740
ToppCell	356C-Myeloid-Dendritic-cDC2\|356C / Donor, Lineage, Cell class and subclass (all cells)	ABL2 HLA-DQA1 GPAT3 REV3L ADAM28 CIITA	5.43e-05	195	151	6	4c9a2167d8cfe40dfd609c303ada5b5ef800bd8f
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Myeloid\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-DQA1 DAPK1 ITGAX ADAM28 CIITA C1QB	5.43e-05	195	151	6	f289a44010788853d7726d4b5aa75f3c62186c08
ToppCell	(010)_cDC\|World / immune cells in Peripheral Blood (logTPM normalization)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.43e-05	195	151	6	4aabb3f5ce70100e4d98d7fa9f8d12e84fb9fe3d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	WIPI1 DAPK1 ITGAX SLC16A3 C1QB SEMA4A	5.43e-05	195	151	6	0ec1b572bbb92b6da3440139366a4c1743b1ad92
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_9\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA C1QB	5.43e-05	195	151	6	dd28c63b53f2a97e3fac127294a465870dc371b3
ToppCell	IIH-mono3\|IIH / Condition, Cell_class and T cell subcluster	WIPI1 GPAT3 ITGAX ADAM28 SLC16A3 C1QB	5.43e-05	195	151	6	c6dd5af582d257be64b718e30f60220c1bf1738a
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_9\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA C1QB	5.43e-05	195	151	6	d6ff38535898f90be6719cd5152291f2f4f8a746
ToppCell	COVID-19_Severe-cDC\|COVID-19_Severe / disease group, cell group and cell class	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.43e-05	195	151	6	6419090b19de7b5d5140eaecf231860273da2c0d
ToppCell	PBMC-Control-Myeloid-cDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.58e-05	196	151	6	e1f763fa9c11bf5f4d80e79f70f9485724ac23fe
ToppCell	10x5'-lymph-node_spleen-Myeloid_Dendritic-DC2\|lymph-node_spleen / Manually curated celltypes from each tissue	HLA-DQA1 GPAT3 DAPK1 ITGAX C1QB SEMA4A	5.58e-05	196	151	6	9666b5380e2b2a3c3b56a8c769817a1df8820ed6
ToppCell	Control-Myeloid-cDC\|Control / Disease group, lineage and cell class	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.58e-05	196	151	6	85d92bc226cc28384c30991cc4ebb02ec2e3ec99
ToppCell	356C-Myeloid-Dendritic\|356C / Donor, Lineage, Cell class and subclass (all cells)	ABL2 HLA-DQA1 GPAT3 ADAM28 CIITA C1QB	5.58e-05	196	151	6	1425eb35bd170d434c47390773e5c74c30c2f592
ToppCell	healthy_donor-Myeloid-Dendritic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.58e-05	196	151	6	ea590b8ea3d13ff93cb5863a44936b0cfdf3b868
ToppCell	ILEUM-non-inflamed-(3)_moDC\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	HLA-DQA1 DAPK1 ITGAX ADAM28 CIITA C1QB	5.58e-05	196	151	6	e10f01172fd076d6892906853f9375d4c3058951
ToppCell	PBMC-Control-Myeloid-cDC-cDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.58e-05	196	151	6	553c22c7d48f3b4f6f2b2f10d6e668c5ebb09e8c
ToppCell	COVID-19_Moderate-cDC\|World / disease group, cell group and cell class	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.58e-05	196	151	6	92a236adf386f05d020b1954bbdc5bd32346cbf0
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.58e-05	196	151	6	0bac14c018487ca67e7f9255b5f186e7ae665774
ToppCell	PBMC-Control-Myeloid-cDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.58e-05	196	151	6	d376168e15ec1cf618723259966c76be3698b9b0
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.58e-05	196	151	6	33345338c825484960daa1ed82a19df38ccfc5c0
ToppCell	PBMC-Control-Myeloid-cDC-cDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.58e-05	196	151	6	4a9095ba3f6709f88f32bf09184553f4bd211f43
ToppCell	healthy_donor-Myeloid-Dendritic-cDC\|healthy_donor / Disease condition, Lineage, Cell class and subclass	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.58e-05	196	151	6	aac79fc45cab4a16e2fa02652ece0999591261a5
ToppCell	PBMC-Mild-Myeloid-cDC-cDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.74e-05	197	151	6	9162ede5572326c00ede0769fe7f4e0dd14d2340
ToppCell	PBMC-Mild-Myeloid-cDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.74e-05	197	151	6	021c9c48375259b808e1f36a029c4fe6971c00eb
ToppCell	PBMC-Mild-Myeloid-cDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.74e-05	197	151	6	18df0e447bcea2a405a357563f87bacc57466227
ToppCell	Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_2\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	TOPAZ1 HLA-DQA1 ITGAX ADAM28 CIITA C1QB	5.74e-05	197	151	6	febafd8f0f5bb9a09f496f240e6b6b5e9275669b
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Macrophages\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-DQA1 DAPK1 ITGAX ADAM28 CIITA C1QB	5.74e-05	197	151	6	e698a0bbb20bd4868ff4348f2ac9f609942b55fa
ToppCell	PBMC-Mild-Myeloid-cDC-cDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.74e-05	197	151	6	0460b6907743a354792b5bc40bff01aac7c41684
ToppCell	COVID-19_Mild-Myeloid-cDC\|COVID-19_Mild / Disease group, lineage and cell class	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.74e-05	197	151	6	2901904b8a791fac2668fd737eff7e7144378db4
ToppCell	Monocytes-cDCs\|World / Immune cells in Kidney/Urine in Lupus Nephritis	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.74e-05	197	151	6	3388c104af4c6a05988e102627e0c5e34d9dcc45
ToppCell	Healthy/Control-cDC\|World / Disease group and Cell class	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.74e-05	197	151	6	4497d4073f4d3e74de907325fba9eb4af5766bf4
ToppCell	Healthy/Control-cDC\|Healthy/Control / Disease group and Cell class	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.74e-05	197	151	6	926423aae9fcf654f84b0f7621103a6a22d3aced
ToppCell	Healthy_donor-cDC\|World / disease group, cell group and cell class (v2)	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.74e-05	197	151	6	a545fe3a80cd721bf01115bbb645753840ec9f40
ToppCell	COVID-19_Moderate-cDC\|COVID-19_Moderate / disease group, cell group and cell class	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.74e-05	197	151	6	ff45a212434a1b128e1a217c6abdec6380938da9
ToppCell	Healthy-cDC\|World / disease group, cell group and cell class	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.91e-05	198	151	6	8976f8d26cb7ff79f74def138c4bbbb0bc2eaf00
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DQA1 GPAT3 ITGAX ADAM28 C1QB SEMA4A	5.91e-05	198	151	6	d0371e2ca9e25727b35985940f6228f9d8e49727
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DQA1 GPAT3 ITGAX ADAM28 C1QB SEMA4A	5.91e-05	198	151	6	08ad0bece508bb4f9cc126d94839b5c89ce21ba8
ToppCell	distal-Hematologic-Interstitial_Macrophage\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ABL2 HLA-DQA1 ITGAX SLC16A3 C1QB SEMA4A	5.91e-05	198	151	6	a35b43d38e18c6f8f0cd9015b8e23f71c729f023
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_2\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	HLA-DQA1 ITGAX ADAM28 SLC16A3 CIITA C1QB	5.91e-05	198	151	6	115f564af8d7b89ac0331d3831faaef694043fd4
ToppCell	Healthy-cDC\|Healthy / disease group, cell group and cell class	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.91e-05	198	151	6	4cf874333b9fd6cd22ee647cd12c032fc6d05740
ToppCell	COVID-19_Severe-cDC\|COVID-19_Severe / Disease condition and Cell class	HLA-DQA1 ADAM28 GPR146 CIITA C1QB PRPF19	5.91e-05	198	151	6	e0b16627a347e245bedd71b1e0ccdb46c1c1bd6d
ToppCell	COVID-19_Severe-cDC-\|COVID-19_Severe / Disease condition and Cell class	HLA-DQA1 ADAM28 GPR146 CIITA C1QB PRPF19	5.91e-05	198	151	6	3914140238598914674c08c5ad83354b9485825f
ToppCell	COVID-19_Severe-cDC\|World / disease group, cell group and cell class	HLA-DQA1 GPAT3 ITGAX ADAM28 CIITA SEMA4A	5.91e-05	198	151	6	c452334249f047265ae89dcabe7de446d968cae6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DQA1 NLRP1 ITGAX ADAM28 CIITA C1QB	6.07e-05	199	151	6	04adf46975aa4194ea40c7480f8a517def5d929c
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	HLA-DQA1 ITGAX ADAM28 SLC16A3 CIITA C1QB	6.07e-05	199	151	6	d330e28075096a09da3c27db8b52e364967c1e34
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive-Alveolar_macrophage_MT-positive_L.1.0.1.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYADM ABL2 DONSON ITGAX C1QB PLEC	6.07e-05	199	151	6	8efa724d47b95194d42907ffae17284c3953605e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	WIPI1 DAPK1 ITGAX DENND4B C1QB SEMA4A	6.07e-05	199	151	6	667b8b47a5b388506e3177b46747267fad8024f6
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYADM ABL2 DONSON ITGAX C1QB PLEC	6.07e-05	199	151	6	fd1a9f9ab5eeb8c50005304715bb0f35b7926935
ToppCell	Biopsy_Control_(H.)-Epithelial-MUC5AC+_High\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	CYP2F1 CD177 ADAM28 KISS1 MUC5AC NOTCH3	6.07e-05	199	151	6	a5240868cea40574ed4ee45eb27a00c1812957ed
Drug	clozapine; Up 200; 10uM; MCF7; HT_HG-U133A	HIVEP2 ZNF318 DALRD3 PASK RPAP1 EDAR SLC16A3 PLEC MINDY1	6.93e-06	197	151	9	6947_UP
Drug	CP-645525-01 [287190-82-3]; Down 200; 10uM; MCF7; HT_HG-U133A	ABL2 CENPO TMCO6 ARHGEF17 DALRD3 SLC16A3 UCN C1QB HR	6.93e-06	197	151	9	7522_DN
Drug	D00992	NLRP1 ORM1 ORM2 HPX MUC5AC	2.43e-05	52	151	5	CID011954225
Drug	norlorcainide	ORM1 ORM2	4.37e-05	2	151	2	CID000162188
Drug	carocainide	ORM1 ORM2	4.37e-05	2	151	2	CID000071970
Drug	2,4,4-trimethyl-2-pentanol	ORM1 ORM2	4.37e-05	2	151	2	CID000094740
Drug	3-phenylindole	ORM1 ORM2	4.37e-05	2	151	2	CID000096502
Drug	norketamine	FBLN5 ORM1 ORM2	4.54e-05	11	151	3	CID000123767
Drug	bromacil	TFPI UCN SDC1	4.54e-05	11	151	3	CID000009411
Drug	Zidovudine, AZT [30516-87-1]; Up 200; 15uM; PC3; HT_HG-U133A	NLRP1 NCBP1 TMCO6 ARHGEF17 WNK1 TFAP2C TFPI PASK	4.55e-05	193	151	8	6733_UP
Drug	Thiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A	C14orf93 TTC28 EPB41L5 DALRD3 USP19 MITF HPX NOTCH3	4.55e-05	193	151	8	2894_DN
Drug	ICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A	ITGAX PASK ORM2 HEATR6 RPAP1 SLC16A3 AP5Z1 PLEC	4.72e-05	194	151	8	1179_DN
Drug	Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; MCF7; HT_HG-U133A	PLXNA3 ABCA2 CENPO TNS2 FEM1C UCN ELL HR	5.08e-05	196	151	8	4125_DN
Drug	Isosorbide dinitrate [87-33-2]; Down 200; 17uM; PC3; HT_HG-U133A	MINDY2 FAAP100 PASK EDAR SLC16A3 ELL NOTCH3 HR	5.08e-05	196	151	8	3720_DN
Drug	Clopamide [636-54-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A	MOK ABCA2 PNO1 WNK1 TFAP2C TFPI AP5Z1 HR	5.26e-05	197	151	8	3220_DN
Drug	LY294002; Up 200; 10uM; PC3; HG-U133A	HIVEP2 DAPK1 TMCO6 FEM1C MINDY2 TFPI IL1RAPL2 MINDY1	5.46e-05	198	151	8	461_UP
Drug	Oleandomycin phosphate [7060-74-4]; Up 200; 5uM; HL60; HG-U133A	DAPK1 NLRP1 ZNF318 ORM2 SBNO1 PLEC SDC1 NOTCH3	5.46e-05	198	151	8	2018_UP
Drug	15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A	TNS2 ANKMY1 FAAP100 TFAP2C ARAP3 SEMA4A ELL HR	5.65e-05	199	151	8	7494_DN
Disease	cerebral palsy (implicated_via_orthology)	AGAP9 AGAP7P AGAP4 AGAP6	1.06e-07	10	142	4	DOID:1969 (implicated_via_orthology)
Disease	MEHMO syndrome (implicated_via_orthology)	EIF2S3B EIF2S3	2.30e-05	2	142	2	DOID:0060801 (implicated_via_orthology)
Disease	hypopituitarism (implicated_via_orthology)	EIF2S3B EIF2S3	3.41e-04	6	142	2	DOID:9406 (implicated_via_orthology)
Disease	serine protease inhibitor Kazal-type 2 measurement	ORM1 ORM2	3.41e-04	6	142	2	EFO_0802054
Disease	tissue factor pathway inhibitor measurement	TFPI ORM1	4.75e-04	7	142	2	EFO_0007968
Disease	leukodystrophy (implicated_via_orthology)	EIF2S3B EIF2S3	8.10e-04	9	142	2	DOID:10579 (implicated_via_orthology)
Disease	left ventricular ejection fraction measurement	HLA-DQA1 MITF PLEC	9.46e-04	40	142	3	EFO_0008373
Disease	coagulation factor XA measurement	ORM1 ORM2	1.23e-03	11	142	2	EFO_0020266
Disease	factor VIII deficiency (is_implicated_in)	HLA-DQA1 TFPI	1.23e-03	11	142	2	DOID:12134 (is_implicated_in)
Disease	sleep disorder (implicated_via_orthology)	TFAP2E TFAP2C	1.23e-03	11	142	2	DOID:535 (implicated_via_orthology)
Disease	outer ear morphology trait	HIVEP2 EDAR	1.47e-03	12	142	2	EFO_0007664
Disease	coagulation factor X measurement	ORM1 ORM2	1.73e-03	13	142	2	EFO_0020265
Disease	juvenile rheumatoid arthritis (is_implicated_in)	HLA-DQA1 CIITA	1.73e-03	13	142	2	DOID:676 (is_implicated_in)
Disease	inositol measurement	ELL NOTCH3	2.01e-03	14	142	2	EFO_0010504
Disease	lobe size	HIVEP2 EDAR	2.01e-03	14	142	2	EFO_0007666
Disease	diffuse large B-cell lymphoma	CDC42BPB ARAP3	2.01e-03	14	142	2	EFO_0000403
Disease	Non-steroidal anti-inflammatory and antirheumatic product use measurement	HLA-DQA1 LMAN1L	2.32e-03	15	142	2	EFO_0009935
Disease	serum urea measurement	ASH1L EPB41L5 ZNF318 SLC16A3 SEMA4A	2.58e-03	195	142	5	EFO_0009795
Disease	systemic lupus erythematosus, COVID-19	HLA-DQA1 ITGAX RAVER1	2.77e-03	58	142	3	MONDO_0007915, MONDO_0100096
Disease	celiac disease	HLA-DQA1 CNOT6 LMAN1L CIITA	3.27e-03	126	142	4	EFO_0001060
Disease	Age-related macular degeneration	FBLN5 HMCN1	3.35e-03	18	142	2	cv:C0242383
Disease	cystatin C measurement	HIVEP2 HLA-DQA1 EPB41L5 RPAP1 EDAR MITF MINDY1	3.41e-03	402	142	7	EFO_0004617
Disease	RS-warfarin measurement	MATN1 TMEM215 NHSL1 SCN5A	3.46e-03	128	142	4	EFO_0803325
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	PALB2 SEMA4A	3.73e-03	19	142	2	C1333991
Disease	angiopoietin-1 receptor measurement	HLA-DQA1 KIRREL3	3.73e-03	19	142	2	EFO_0010600
Disease	Colorectal cancer, hereditary nonpolyposis, type 1	PALB2 SEMA4A	3.73e-03	19	142	2	C2936783
Disease	schizophrenia (implicated_via_orthology)	HIVEP2 GRM5 SBNO1	4.35e-03	68	142	3	DOID:5419 (implicated_via_orthology)
Disease	vitiligo (is_implicated_in)	HLA-DQA1 NLRP1	4.55e-03	21	142	2	DOID:12306 (is_implicated_in)
Disease	ovarian carcinoma	TTC28 DAPK1 NLRP1 TFAP2C CNOT6 N4BP2	4.71e-03	321	142	6	EFO_0001075

Protein segments in the cluster

Peptide	Gene	Start	Entry
PLPCTELSLGQQLLR	AGAP4	556	Q96P64
PPLLIAAGCGNIQIL	DAPK1	381	P53355
LGLINASLLPPPECT	SLC4A9	596	Q96Q91
PTLQLPGCLNSLTEQ	MLLT6	921	P55198
CLPAVPGILNLNSQL	ADGRF3	231	Q8IZF5
PLALGLQTPLQIDCS	ASH1L	1566	Q9NR48
LLLPDLQPQSNFCLL	EGFL6	451	Q8IUX8
PTVRLGLPLLTDCAQ	ELL	421	P55199
FLAPLPCTELSLGQQ	AGAP9	621	Q5VTM2
PLSLIQPQDIVCLGV	ARAP3	726	Q8WWN8
LSPPECLNASLLGGV	TFAP2C	251	Q92754
HPNLVQLLGVCTLEP	ABL2	341	P42684
LSNCLFNAPLPTDII	ADAM28	391	Q9UKQ2
SLSCLNLPEGPIQFV	CIITA	216	P33076
PLCSLAKALLGPQNL	ARHGEF37	346	A1IGU5
LCPGLTAPILIQAQL	CSRNP2	371	Q9H175
QDLQDLLPQLGLVPC	ABHD11	121	Q8NFV4
IALLPCESPKAQQLS	ARMH1	191	Q6PIY5
SLLPLLEAQIPLCAN	ORM2	11	P19652
PFLLILVCTAPENLN	B3GALT4	71	O96024
FVLLACPLGALAPQL	DPH2	336	Q9BQC3
PAPVALGLCTLQTTL	CCDC142	421	Q17RM4
ATLGLPACPEQLQVL	AP5Z1	71	O43299
PLADSLQELSLAGCP	DMAC2	171	Q9NW81
SLLVNGSNITPPCEL	CCKAR	6	P32238
GFILPLPGVQALLCQ	CD177	11	Q8N6Q3
TPDLVQGLASPLLRC	DIPK2B	161	Q9H7Y0
PVTLGQPNILICLVD	HLA-DQA1	121	P01909
ISCPLNSPVQLAGLK	ARMCX5	401	Q6P1M9
PLPCTELSLGQQLLR	AGAP6	556	Q5VW22
SPPECLNASLLGGVL	TFAP2E	246	Q6VUC0
CSAAQLQPQPATLLG	NUMBL	521	Q9Y6R0
DALLCVANLPPSLTQ	RAVER1	131	Q8IY67
IPNSELLPFLQNLCS	PAAT	326	Q9H8K7
PPLSLGLQLEFCDSN	OR6C2	156	Q9NZP2
PLSILGNLLLLCSQD	CYP2F1	36	P24903
NGDLNGLLVPDPLCS	EDC4	41	Q6P2E9
CFLLGPTQLTQRLPV	ITGAX	126	P20702
SGNQLGALPPQLCSL	LRRC57	116	Q8N9N7
LAAVQLPDGFNLLCP	ARHGEF17	1976	Q96PE2
CPADPLQLNKALSII	FEM1C	431	Q96JP0
ELFPKLLCLDGQQSP	NXF3	301	Q9H4D5
LIAGGQLLSCLSPQP	PASK	471	Q96RG2
ISPGNSPLQGLINCL	KRBA1	201	A5PL33
SDPTLLPNITLGCEI	GRM5	81	P41594
LLLQALCSPGLAPQS	MATN1	16	P21941
LIELCKLQPGSLPQV	NCBP1	376	Q09161
SPVFLCALSPLGQLL	SLC16A3	156	O15427
LQECLSTGSLPLGPA	LMAN1L	491	Q9HAT1
APDKQGSPELCLLSL	EDAR	291	Q9UNE0
SLQDPGLQDIPCLAL	HR	476	O43593
GLQDIPCLALPAKLA	HR	481	O43593
ALLSLCDSAVPLNAP	NHSL1	496	Q5SYE7
LLPSGELLCPSPSLQ	PLXNA3	586	P51805
LQTLLTVQLPFCGPN	OR4S1	156	Q8NGB4
AQPLGPQLRDLCSLA	NLRP1	561	Q9C000
CVLSLGLLNPVAVPL	NOTCH3	2156	Q9UM47
LPEVQLLLQQPCSSG	HEATR6	596	Q6AI08
LPAGVPSLAACLQLL	HEXD	311	Q8WVB3
LGLLAPGEQSLPCTE	KISS1	41	Q15726
ALLPSQCGDNLESPL	MINDY1	56	Q8N5J2
FLLNSCQPTPGLETL	KRTAP3-2	66	Q9BYR7
FLLNSCQPTPGLETL	KRTAP3-3	66	Q9BYR6
ILLNLGECTNVLPIP	MYADM	221	Q96S97
GIPLLTTNLSPQCLS	MOK	246	Q9UQ07
TEGLICLNKNQLPPI	MUC5AC	1646	P98088
LSQLPDLLLQACPFG	AP5M1	156	Q9H0R1
GCDQGLVPIPLLANL	ARSA	171	P15289
ARTAICNLILGNPPS	PNO1	221	Q9NRX1
LGPLACLTTQLPELN	HMGXB4	566	Q9UGU5
LPELNGCPKQVLSNT	HMGXB4	576	Q9UGU5
LNSEGTLNLLNCEPP	CDC42BPB	1506	Q9Y5S2
LQSPVVLCGLPDGQL	FAAP100	236	Q0VG06
QLTLPCTLLAGNPIP	HMCN1	906	Q96RW7
GNLISLLCESSGIPP	HMCN1	2211	Q96RW7
AVPLPANACGLLRNS	MRGPRG	136	Q86SM5
SIAQISLLLPLPFCG	OR4D9	156	Q8NGE8
DLLLGQCTALLPPVS	PALB2	1141	Q86YC2
IPPLLILSCGNTSVN	OR5V1	181	Q9UGF6
IPGILALDLCPSDTN	PRPF19	221	Q9UMS4
SCLKIILSNPPSQGD	PRIM2	366	P49643
LIPLLQLINPGSTQC	RETNLB	11	Q9BQ08
CIPLNIDLLNSPDLL	EPB41L5	446	Q9HCM4
PLQLQPQASGASCLA	DMRTC2	266	Q8IXT2
LPILIFPEGTCINNT	GPAT3	296	Q53EU6
RALACPPGSLETLQL	HSD17B1	51	P14061
CTLAASEAAPLLNPL	C14orf93	186	Q9H972
CTLPGLSLLPDDQSQ	CENPJ	186	Q9HC77
PSALQSPLGCLLSLL	ABCA2	2376	Q9BZC7
PLPCTELSLGQQLLR	AGAP7P	556	Q5VUJ5
PNLPLTKGLGSALCV	ANKMY1	721	Q9P2S6
LIDISQAQLSCTGPP	C1QB	21	P02746
PFLIGILSCSLPQLQ	DENND2C	741	Q68D51
SLLPLLEAQIPLCAN	ORM1	11	P02763
LLLCQPVSSPLPLSG	DENND4B	381	O75064
CGLHPNTLEQLSQIP	DONSON	531	Q9NYP3
LNSLLLPKNTPCLNA	GEN1	526	Q17RS7
PVISLRAGDPLNLTC	KIRREL3	156	Q8IZU9
LRCAPTPAGLSLQLQ	DALRD3	76	Q5D0E6
FAALLTGPLQRNPLC	CENPO	201	Q9BU64
TGPLQRNPLCNLLSF	CENPO	206	Q9BU64
LLLIAGNESCPQPQT	EIF2S3B	156	Q2VIR3
LLKQPLIPGSSLSLC	ATRIP	316	Q8WXE1
TILALCLPSPGNAQA	FBLN5	11	Q9UBX5
LPACQDLQLGLSLLS	GPR146	16	Q96CH1
TCPVLLQADPFLGLA	S1PR5	281	Q9H228
VGLIIPANCVSPLVN	SBNO1	1346	A3KN83
LLQPRILFSNCPQGL	CFAP47	956	Q6ZTR5
PLVLCADLNSLPDSG	CNOT6	406	Q9ULM6
LLPPNQTGIFLLCLI	OR2L13	16	Q8N349
LCQALVPPGVAALLA	GRIN3B	91	O60391
KALPQPQNVTSLLGC	HPX	446	P02790
NENGPCPLLAILNVL	MINDY2	261	Q8NBR6
FQGLLPLTELSVCPL	PLEKHN1	136	Q494U1
LLNLKTSPLNPGTLC	TDRD6	1026	O60522
IHCLVPDLLQITGNP	SOCS5	366	O75159
LVLQNPSLGSCPSEV	NBR1	181	Q14596
QAPLALPGLLSPSCL	RIPPLY1	26	Q0D2K3
YCNLPLTLLNGQLPL	IL1RAPL2	641	Q9NP60
SCPRLVLLNLQGNPL	RABGGTA	531	Q92696
FLKAQLLCTQPGQLP	SEMA4A	286	Q9H3S1
KPAALAAQGQLPSCI	SCN5A	991	Q14524
CALALSLQPALPQIV	SDC1	11	P18827
QLEKLCDSLLSGTPP	SLC38A8	126	A6NNN8
VPPKFLGDSLLLLNC	SPATC1L	311	Q9H0A9
NSIPLVLCADLNSLP	CNOT6L	401	Q96LI5
PACDSILGQTLLPEG	TTPAL	306	Q9BTX7
IPPLNSQTCLLGSEE	USP19	211	O94966
TLGNIPLLAIGPAIC	TMEM215	36	Q68D42
IEIPVLCLLVNGDPN	TRPM5	221	Q9NZQ8
LIPSTGLCSPDLVNR	MITF	406	O75030
PLQGLDTCQSPLTQA	REV3L	16	O60673
PLQLSGQLNSLPCSL	TMEM94	1051	Q12767
SLLQASLQAPGKRCP	STPG3	216	Q8N7X2
LACVQLGLQLLPEGP	USP35	101	Q9P2H5
PCLSPEALLVGQASQ	nan	281	A8MX80
QLCALAGPGPDLLLQ	PRRT4	676	C9JH25
NLFGQPLVCLLSPTA	SCAI	446	Q8N9R8
QLLPQGIVPALAACI	TMCO6	186	Q96DC7
CLPAAISAQSILELP	USF3	226	Q68DE3
CRPDQLTGLSLLPLS	PLEC	3336	Q15149
VLPNLNLDCRLPGLT	RPAP1	1191	Q9BWH6
NTAPLTLCPLNIGSQ	TRIM21	456	P19474
CLLLNLAPAPLNADS	TFPI	16	P10646
PCLSPEALLVGQASQ	nan	251	A8MV72
CLLVPPLNLSGRQED	TOPAZ1	1031	Q8N9V7
QCSSTLQSLLGLPNP	TTC28	1816	Q96AY4
GLPNPALQALCKLIT	TTC28	1826	Q96AY4
PCLSPEALLVGQASQ	nan	281	Q8N9G6
PCLSPEALLVGQASQ	nan	281	A8MUA0
PLLLALALASVPCAQ	SYCN	6	Q0VAF6
QLVLLPGSDATPRLC	TSPEAR	216	Q8WU66
LDIPANPTGLCALSI	WIPI1	136	Q5MNZ9
CDSNATALELPGLPL	WNK1	86	Q9H4A3
QTLPLGLESSIPLCL	HIVEP2	1411	P31629
CLNGQALALPAPSRT	PRSS50	356	Q9UI38
LNPCPAGIIDQLSVI	WDR7	386	Q9Y4E6
LARVSEGQLLCATPP	MST1R	726	Q04912
IPNSELLPFLQNLCS	nan	161	Q499Y3
DPSKCSSLELGPLQL	ZNF318	2196	Q5VUA4
AALLLLVQLCPGSSQ	UCN	11	P55089
GPQQLCISLEPALLL	TNS2	346	Q63HR2
LLLIAGNESCPQPQT	EIF2S3	156	P41091
LDASEPQACLNLPGL	N4BP2	286	Q86UW6